KEGG: cgr:CAGL0G03245g
CAGL0G03245g is a mitochondrial outer membrane protein found in the pathogenic yeast Candida glabrata. As a transmembrane protein, it contains multiple membrane-spanning domains that anchor it to the outer mitochondrial membrane. The protein consists of 751 amino acids with a molecular structure that likely includes hydrophobic regions characteristic of membrane proteins.
To characterize CAGL0G03245g experimentally, researchers typically employ:
Subcellular fractionation followed by Western blotting
Fluorescent protein tagging (GFP fusion) for localization studies
Proteomic analysis of purified mitochondrial membranes
Prediction software for transmembrane domain identification
The amino acid sequence suggests potential functional domains, although these would require experimental validation through mutational analysis and functional assays specific to mitochondrial membrane proteins.
Recombinant CAGL0G03245g is produced using an in vitro E. coli expression system, with the following methodological approach:
Gene amplification and cloning into an expression vector containing an N-terminal 10xHis tag
Transformation into an appropriate E. coli strain optimized for membrane protein expression
Culture growth under controlled conditions with induction of protein expression
Cell harvest and membrane isolation
Solubilization using appropriate detergents to extract membrane proteins
Purification via metal affinity chromatography exploiting the His-tag
Further purification steps such as size exclusion chromatography if needed
Quality control including SDS-PAGE and Western blotting
The expression and purification of membrane proteins present special challenges compared to soluble proteins, often requiring optimization of detergent conditions and buffer compositions to maintain native conformation and function .
For optimal stability and functionality of recombinant CAGL0G03245g, the following storage conditions are recommended:
| Storage Duration | Recommended Temperature | Additional Considerations |
|---|---|---|
| Short-term | -20°C | Avoid repeated freeze-thaw cycles |
| Extended storage | -20°C to -80°C | Aliquot before freezing |
| Working aliquots | 4°C | Use within one week |
The shelf life of liquid preparations is approximately 6 months when stored at -20°C/-80°C, while lyophilized forms can maintain stability for up to 12 months under the same conditions. As with many membrane proteins, the presence of appropriate stabilizing agents in the buffer (glycerol, specific detergents, protease inhibitors) is crucial for maintaining structural integrity during storage .
Characterizing the function of CAGL0G03245g requires specialized assays for mitochondrial membrane proteins:
Protein-Protein Interaction Studies:
Co-immunoprecipitation with potential binding partners
Proximity labeling techniques (BioID, APEX) for in vivo interaction mapping
Yeast two-hybrid screening with modifications for membrane proteins
Surface plasmon resonance for direct binding kinetics
Mitochondrial Function Assays:
Membrane potential measurements using fluorescent dyes
Protein import assays if involved in mitochondrial protein translocation
Mitochondrial morphology analysis in knockout vs. wild-type strains
Respiratory capacity measurements
In vitro Reconstitution:
Liposome incorporation for transport or channel activity studies
Electrophysiological measurements if the protein forms channels
Genetic Approaches:
Phenotypic analysis of gene deletion mutants
Complementation studies to verify functional roles
Site-directed mutagenesis of conserved residues
Assay selection should be guided by bioinformatic predictions of protein function and preliminary phenotypic observations in mutant strains .
Comparative analysis of CAGL0G03245g with other mitochondrial proteins provides evolutionary and functional insights:
Sequence-Based Comparison:
Multiple sequence alignment with orthologs from related Candida species
Identification of conserved domains and motifs
Phylogenetic analysis to determine evolutionary relationships
Calculation of selection pressure (dN/dS ratios) on different protein regions
Structural Comparison:
Homology modeling based on proteins with known structures
Prediction of transmembrane topology and comparison across species
Identification of conserved structural features
Functional Comparison:
Cross-species complementation experiments
Comparative phenotypic analysis of deletion mutants
Assessment of expression patterns under similar conditions
Methodological Approach:
Database mining (UniProt, FungiDB) for ortholog identification
CLUSTAL or MUSCLE for multiple sequence alignment
MEGA or PhyML for phylogenetic tree construction
Structural prediction using AlphaFold2 or similar tools
This comparative approach can reveal whether CAGL0G03245g performs conserved functions common to all Candida species or represents a specialized adaptation in C. glabrata .
Understanding CAGL0G03245g expression patterns requires integrated genomic and proteomic approaches:
Transcriptomic Analysis:
RNA-Seq under various environmental conditions
qRT-PCR for targeted expression analysis
Promoter analysis to identify regulatory elements
ChIP-Seq to identify transcription factors regulating expression
Proteomic Methods:
Targeted mass spectrometry (MRM/PRM) for protein quantification
SILAC or TMT labeling for comparative proteomics
Pulse-chase experiments to determine protein turnover rates
Post-translational modification analysis
Reporter Systems:
Promoter-GFP fusions to monitor expression in live cells
CRISPR interference for controlled gene repression
Ribosome profiling to assess translation efficiency
Integrated Data Analysis:
Correlation of transcript and protein levels
Network analysis to identify co-expressed genes
Pathway enrichment analysis
These methods should be applied across relevant conditions such as during host cell interaction, exposure to stress factors, or antifungal treatment to understand the physiological context of CAGL0G03245g expression .
While specific data on CAGL0G03245g's role in virulence is limited, insights can be drawn from studies of other membrane proteins in C. glabrata:
Potential Mechanisms in Pathogenesis:
Maintenance of mitochondrial function during phagocytosis
Contribution to stress response networks (similar to CgDtr1's role)
Involvement in metabolic adaptation within host environments
Possible role in resistance to host defense mechanisms
Experimental Assessment Approaches:
Infection models such as Galleria mellonella larvae (as established for other virulence factors)
Competitive infection assays comparing wild-type and deletion mutants
Ex vivo macrophage infection assays to assess phagocyte survival
Transcriptional analysis during host-pathogen interaction
Correlative Evidence:
Expression pattern analysis during infection phases
Assessment of virulence attenuation in deletion mutants
Restoration of virulence through complementation
Other membrane proteins in C. glabrata, such as CgDtr1 (encoded by CAGL0M06281g), have been demonstrated to influence pathogenesis by enhancing survival within host immune cells and resistance to stress factors. CgDtr1 specifically increases C. glabrata virulence in the Galleria mellonella infection model by improving proliferation in hemolymph and resistance to hemocyte-mediated killing .
Mitochondrial membrane proteins often mediate cellular adaptation to environmental stress:
Potential Stress Response Functions:
Oxidative stress management (particularly relevant for mitochondrial proteins)
pH adaptation (similar to CgDtr1's role in acetic acid resistance)
Nutrient limitation response
Temperature stress adaptation
Experimental Approaches to Assess Stress Roles:
| Stress Condition | Methodology | Key Measurements |
|---|---|---|
| Oxidative stress | H₂O₂ or menadione exposure | Survival rates, ROS accumulation, mitochondrial membrane potential |
| pH stress | Growth in acidic media | Intracellular pH, growth kinetics, expression changes |
| Nutrient limitation | Carbon/nitrogen starvation | Mitochondrial morphology, respiratory capacity, ATP production |
| Antifungal exposure | Sub-inhibitory drug concentrations | Drug sensitivity, membrane integrity, stress response pathway activation |
Comparative Analysis:
Stress phenotypes in wild-type vs. deletion mutants
Complementation studies to confirm specificity
Cross-resistance patterns to multiple stressors
The established role of other membrane transporters such as CgDtr1 in mediating acetic acid resistance suggests CAGL0G03245g might similarly contribute to specific stress tolerance mechanisms relevant during host colonization and infection .
Structural insights into CAGL0G03245g can facilitate rational approaches to antifungal development:
Structure Determination Approaches:
X-ray crystallography (challenging for membrane proteins)
Cryo-electron microscopy for membrane protein structures
NMR spectroscopy for specific domains
Computational structure prediction using AlphaFold2 or RoseTTAFold
Drug Target Assessment Criteria:
Identification of druggable pockets or channels
Evaluation of essentiality for fungal survival
Assessment of structural divergence from human homologs
Analysis of conservation across resistant Candida strains
Structure-Based Drug Design Workflow:
Virtual screening against predicted binding sites
Fragment-based drug discovery targeting key functional regions
Molecular dynamics simulations of protein-ligand interactions
Structure-activity relationship studies for lead optimization
Validation Methods:
Binding assays using surface plasmon resonance or isothermal titration calorimetry
Functional inhibition assays
Co-crystallization with lead compounds
Mutagenesis of predicted binding site residues
Targeting fungal-specific features of mitochondrial membrane proteins can potentially provide selective antifungal activity with reduced host toxicity .
Membrane proteins present specific experimental challenges that require specialized approaches:
Expression and Purification Challenges:
Low expression levels
Protein aggregation during extraction
Difficulty maintaining native conformation
Loss of function during purification
Methodological Solutions:
Use of specialized E. coli strains (C41/C43, Lemo21)
Optimization of detergent screening (DDM, LMNG, GDN)
Expression as fusion proteins with solubility enhancers
Co-expression with chaperones
Nanodiscs or liposome reconstitution to maintain native environment
Functional Analysis Challenges:
Difficult to assess activity outside native membrane
Complex protein-protein interactions
Limited structural information
Troubleshooting Approaches:
| Challenge | Potential Solution | Implementation Method |
|---|---|---|
| Protein aggregation | Detergent optimization | Systematic screening of detergent types, concentrations, and temperature conditions |
| Low expression | Codon optimization | Redesign gene sequence for optimal codon usage in expression host |
| Loss of function | Native-like environment | Reconstitution in liposomes mimicking mitochondrial membrane composition |
| Protein instability | Buffer optimization | Screen additives (glycerol, arginine, specific lipids) to enhance stability |
Addressing these challenges requires iterative optimization and combination of multiple approaches tailored to the specific properties of CAGL0G03245g .
Investigating protein-protein interactions for membrane proteins requires specialized techniques:
In vivo Interaction Methods:
Split-GFP complementation adapted for membrane proteins
Proximity-dependent biotinylation (BioID, TurboID)
FRET/BRET assays for dynamic interaction studies
Membrane yeast two-hybrid systems
In vitro Approaches:
Microscale thermophoresis for detecting interactions in solution
Surface plasmon resonance with captured proteins in nanodiscs
Pull-down assays with stabilized protein complexes
Hydrogen-deuterium exchange mass spectrometry
Computational Prediction:
Protein-protein docking simulations
Coevolution analysis to identify interacting interfaces
Network analysis based on functional genomics data
Validation Strategies:
Mutational analysis of predicted interaction interfaces
In vivo functional assays to confirm biological relevance
Comparative analysis across related species
Structural studies of protein complexes
These approaches should be combined for comprehensive characterization, as each method has inherent limitations when applied to membrane proteins like CAGL0G03245g .
Several cutting-edge technologies show promise for deeper insights into CAGL0G03245g:
Advanced Structural Biology:
Cryo-electron tomography for visualizing proteins in their native membrane environment
Integrative structural biology combining multiple data types
Serial femtosecond crystallography for membrane protein structures
Hydrogen-deuterium exchange mass spectrometry for dynamics studies
Genome Editing Advances:
CRISPR interference for conditional expression modulation
Base editing for precise amino acid substitutions
Prime editing for complex genetic modifications
Saturation mutagenesis combined with deep phenotyping
Single-Cell Technologies:
Single-cell RNA-Seq during infection to capture heterogeneous responses
Spatial transcriptomics to analyze expression in tissue context
Mass cytometry to profile protein expression at single-cell resolution
Microfluidic devices for real-time monitoring of single-cell responses
Systems Biology Approaches:
Multi-omics data integration
Network analysis to position CAGL0G03245g in cellular pathways
Machine learning for predicting functional partners
Metabolic flux analysis to assess mitochondrial function
These technologies could reveal dynamic aspects of CAGL0G03245g function during host-pathogen interactions that are not accessible through conventional approaches .
Cross-species comparative analysis offers valuable insights for therapeutic development:
Evolutionary Conservation Analysis:
Identification of conserved domains as potential broad-spectrum targets
Detection of species-specific features for selective targeting
Analysis of natural variations in drug-binding regions
Assessment of compensatory pathways across species
Functional Comparison Methodologies:
Cross-species complementation to determine functional conservation
Heterologous expression studies to identify crucial regions
Comparative phenotypic profiling across deletion mutants
Analysis of protein-protein interaction networks across species
Therapeutic Implications:
| Comparative Finding | Therapeutic Relevance | Implementation Strategy |
|---|---|---|
| Highly conserved functional domains | Potential broad-spectrum target | Structure-based drug design targeting conserved pockets |
| Species-specific features | Selective anti-C. glabrata activity | Targeting unique structural elements or binding sites |
| Divergence from human homologs | Reduced host toxicity | Exploiting structural differences for selective binding |
| Conservation in resistant strains | Potential to overcome resistance | Targeting regions under functional constraint |
Translation to Drug Development:
Rational design of inhibitors against conserved elements
Species-selective compound libraries
Combination strategies targeting multiple membrane proteins
Repurposing screens using structurally related targets
This comparative approach could identify both broad-spectrum and species-specific therapeutic opportunities while minimizing potential for toxic effects on human mitochondrial functions .